Clinical Trial Update: Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR) [Phase 1]

View source ↗

Summary

Phase 1 trial SOLAR is evaluating loncastuximab tesirine in combination with rituximab following stereotactic radiosurgery for central nervous system lymphoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Zynlonta (loncastuximab tesirine)

Snippet

Sponsor: University of Utah | Conditions: Central Nervous System Lymphoma | Phase 1 | Status: RECRUITING